FDA Inspection 1071035 — Wilgard Pohl, M.D.
The FDA completed an inspection of Wilgard Pohl, M.D. on Sep 27, 2018 in Dresden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dresden (Germany)
Additional Details
Clinical Investigator (CI)